At the European Lung Cancer Congress (ELCC) 2025, AstraZeneca showcased new research that showed how artificial intelligence (AI) could enhance lung cancer risk detection, particularly in healthcare settings with limited resources.
Bayer has declared that the company is gearing up for market launch this year about the two newer drugs for its cardiology and women's health portfolios for its...
In a significant initiative for drug safety and regulatory efficiency, the Gujarat Food and Drug Control Administration (FDCA) will procure...
Akums Drugs & Pharmaceuticals Ltd., India's leading contract development and manufacturing organization (CDMO), has announced the launch of a pioneering Ripasudil-Timolol combination therapy for glaucoma treatment.
The World Health Organization (WHO) is currently putting malaria rapid diagnostic tests (RDTs) under scrutiny after reports of faint positive lines in tests done to...
Multinational company Anteris Technologies Global Corp, is a head in Structural heart solutions, and it has reached an essential achievement with its DurAVR Transcatheter Heart valve(THV). Over 100 patients suffering from severe aortic stenosis
The Association Indian Medical Device Industry (AiMED) congratulates the government's announcement to operationalise the...
GE HealthCare introduced its new computed tomography (CT) system, intended to support healthcare professionals in diagnosing difficult coronary artery disease (CAD)...
Billionaire Elon Musk announced that his brain chip firm Neuralink intends to conduct its first Blindsight implant by the end of 2025. The artificial visual prosthesis aims to give blind people their sight back...
Glenmark Pharmaceuticals Inc., USA, has announced the commercial availability of Vancomycin Hydrochloride for Injection USP in three single-dose vial strengths: 750 mg/vial, 1.25 g/vial, and 1.5...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")